相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists
Athina Zacharia et al.
VACCINE (2021)
Chronic Chikungunya Arthritis and Rheumatoid Arthritis: What They Have in Common
J. Kennedy Amaral et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes A Randomized Clinical Trial
Grace L. Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort
In-Kyu Yoon et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial
Nina Wressnigg et al.
LANCET INFECTIOUS DISEASES (2020)
Multisectoral Approach to Address Chikungunya Outbreaks Driven by Human Mobility: A Systematic Review and Meta-Analysis
Rashad Abdul-Ghani et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Risks Related to Chikungunya Infections among European Union Travelers 2012-2018
Celine M. Gossner et al.
EMERGING INFECTIOUS DISEASES (2020)
Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus
Moritz U. G. Kraemer et al.
NATURE MICROBIOLOGY (2019)
Chikungunya chronic disease: a systematic review and meta-analysis
Enny S. Paixao et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2018)
Chikungunya outbreak (2017) in Bangladesh: Clinical profile, economic impact and quality of life during the acute phase of the disease
Mohammad Sorowar Hossain et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial
Emil C. Reisinger et al.
LANCET (2018)
Long-term sequelae of chikungunya virus disease: A systematic review
Marielle van Aalst et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2017)
A Virus-Like Particle Vaccine Elicits Broad Neutralizing Antibody Responses in Humans to All Chikungunya Virus Genotypes
Leslie Goo et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus
Adam D. DeZure et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Long-Lasting Immune Protection and Other Epidemiological Findings after Chikungunya Emergence in a Cambodian Rural Community, April 2012
Beatriz Galatas et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial
Lee-Jah Chang et al.
LANCET (2014)
Unique Epitopes Recognized by Antibodies Induced in Chikungunya Virus-Infected Non-Human Primates: Implications for the Study of Immunopathology and Vaccine Development
Yiu-Wing Kam et al.
PLOS ONE (2014)
An Essential Role of Antibodies in the Control of Chikungunya Virus Infection
Fok-Moon Lum et al.
JOURNAL OF IMMUNOLOGY (2013)
Chronic Joint Disease Caused by Persistent Chikungunya Virus Infection Is Controlled by the Adaptive Immune Response
David W. Hawman et al.
JOURNAL OF VIROLOGY (2013)
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model
Haiyan Chu et al.
VACCINE (2013)
Early Appearance of Neutralizing Immunoglobulin G3 Antibodies Is Associated With Chikungunya Virus Clearance and Long-term Clinical Protection
Yiu-Wing Kam et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Sequential Adaptive Mutations Enhance Efficient Vector Switching by Chikungunya Virus and Its Epidemic Emergence
Konstantin A. Tsetsarkin et al.
PLOS PATHOGENS (2011)
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection
Wataru Akahata et al.
NATURE MEDICINE (2010)
Biology and pathogenesis of chikungunya virus
Olivier Schwartz et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Prophylaxis and Therapy for Chikungunya Virus Infection
Therese Couderc et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218
R Edelman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2000)
分享论文
